AG

Anta Gkelou

Partner at Sofinnova Partners

Paris, Île-de-France

Overview

Work Experience

SP

Sofinnova Partners

  • Partner

    2024 - Current

  • Principal

    2020 - 2024

  • Associate

    2017 - 2020

NP

Noema Pharma

  • Board Observer

    2020

FI

France Invest

  • Member Board Of Directors -35

    2021 - 2024

EP

Enthera Pharmaceuticals

  • Board Observer

    2020 - 2024

NT

Nitrase Therapeutics

  • Board Observer

    2020 - 2024

Institute of blood and vessels

  • Postdoctoral Fellow

    2015 - 2016

    Vascularisation in Alzheimer's disease

I

Inserm

  • Postdoctoral Fellow

    2013 - 2016

    Paris centre of cardiovascular research, PARCC- INSERM U970 Key areas of research: Immunology: The role of mast cells in cardiac function following myocardial infartcion; The role of CXCL12/CXCR4 interactions in regulating cardiac remodeling following myocardial infarction, under the supervision of Dr. Jean-Sebastien Silvestre

National Heart and Lung Institute, Imperial College London, Pfizer

  • Clinical Medical research, CASE studentship with Pfizer

    2008 - 2012

Education

Relevant Websites